Operations

>

Latest News

Stock.adobe.com
Can AI Accelerate Clinical Review at FDA?

July 23rd 2025

With reports that FDA’s AI Elsa is “confidently hallucinating” studies that don’t exist, the use of AI to streamline drug review and speed up approval is not here yet.

How Does the Shift to Early-Stage M&A Change Due Diligence?
How Does the Shift to Early-Stage M&A Change Due Diligence?

May 12th 2025

Bridging the Gap: A Large Pharma Blueprint
Bridging the Gap: A Large Pharma Blueprint

May 9th 2025

Asembia 2025: What Pharma Leaders Must Know About Tariffs, Supply Chains, and Policy Changes
Asembia 2025: What Pharma Leaders Must Know About Tariffs, Supply Chains, and Policy Changes

May 1st 2025

Novartis to Invest $23 Billion in US Manufacturing and R&D Over Five Years
Novartis to Invest $23 Billion in US Manufacturing and R&D Over Five Years

April 11th 2025

Video Interviews

More News

Pharmaceutical Industry Avoids Trump’s Tariffs — For Now

Pharmaceutical Industry Avoids Trump’s Tariffs — For Now

PharmExec Staff
April 4th 2025

Eli Lilly CEO David Ricks to the BBC: “It feels like it'll be hard to come back from here."

Biogen to Establish New Global HQ and Innovation Hub in Massachusetts by 2028

Biogen to Establish New Global HQ and Innovation Hub in Massachusetts by 2028

Don Tracy, Associate Editor
March 24th 2025

The facility, which is set to open amid Biogen’s 50th anniversary, will integrate research and development, technical operations, and commercial teams into one location.

Johnson & Johnson to Invest Over $55 Billion in US Manufacturing Facilities

Johnson & Johnson to Invest Over $55 Billion in US Manufacturing Facilities

Don Tracy, Associate Editor
March 21st 2025

The investment, which is a 25% increase from previous years, will support three new advanced manufacturing facilities, expansions at existing sites, and R&D efforts.